Two-Decade Old US Interstate Compounding Provision Stayed For More Comments

Responding to court ruling, US FDA will explore what it will cost compounding pharmacies to submit to increased state restrictions and oversight of out-of-state compounding quality under a standard MOU that Congress required decades ago.